{"url":"https://whatshealthyandwhy.com/vitamin-c/high-dose-vitamin-c","path":"/vitamin-c/high-dose-vitamin-c","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/vitamin-c/high-dose-vitamin-c.json","markdown":"https://whatshealthyandwhy.com/vitamin-c/high-dose-vitamin-c.md"},"topic":{"slug":"vitamin-c","name":"Vitamin C","url":"https://whatshealthyandwhy.com/vitamin-c"},"slug":"high-dose-vitamin-c","order":2,"title":"High-dose vitamin C","question":"Does high-dose IV vitamin C treat cancer or sepsis?","answer":"High-dose IV vitamin C may lower deaths in sepsis, but the trial missed its main goal; it is not a proven cancer treatment.","description":"IV vitamin C research in cancer and sepsis — controversial, promising, and far from settled","confidence":2,"confidenceNote":"One RCT in 167 sepsis patients missed its primary endpoint but showed lower mortality as a secondary result; cancer support is mechanistic work and a review, not trial results.","evidenceSummary":{"rctCount":1,"observationalCount":1,"metaAnalysisCount":0,"totalParticipants":"167","replicated":false,"newestStudyYear":2019},"category":{"categoryTitle":"What's Good For You","categorySlug":"good-for-you","subcategoryName":"Supplements & Vitamins","subcategorySlug":"supplements","url":"https://whatshealthyandwhy.com/explore/good-for-you/supplements"},"actions":["Ask your oncologist before trying IV vitamin C [1].","Oral vitamin C at 1–3 grams a day in divided doses is generally safe, but it cannot match IV blood levels [1]."],"cautions":["Do not replace cancer treatment with vitamin C; the cited review says ascorbate in cancer treatment still deserves re-examination [1].","High oral doses raise oxalate excretion, a concern for people prone to kidney stones, and can interfere with some lab tests [1].","Sepsis needs hospital care; the trial gave IV vitamin C there, and larger sepsis trials gave mixed results [2]."],"simpleText":"When Linus Pauling claimed that massive doses of vitamin C could treat cancer, most of the medical establishment dismissed him. Decades later, researchers at the NIH discovered something that partly vindicated his intuition: the route of administration matters enormously. Oral vitamin C and intravenous (IV) vitamin C are pharmacologically different interventions [1].\n\nThis distinction — and the research it has spawned — is one of the most interesting stories in modern medicine. It is also one of the most contentious.\n\nThe bottom line: high-dose IV vitamin C is not a proven cancer treatment, but it is no longer fringe science either. Multiple clinical trials are underway, and the mechanisms are better understood than ever.","mediumText":"The core issue with oral vitamin C is a bioavailability ceiling. The intestinal absorption of ascorbic acid is tightly regulated by sodium-dependent vitamin C transporters (SVCT1). At oral doses above about 500 mg, absorption efficiency drops sharply, and renal excretion increases. Even at maximum oral dosing, plasma levels peak around 220 micromol/L. By contrast, IV administration bypasses gut absorption entirely and can achieve plasma concentrations of 10,000-20,000 micromol/L — roughly 50-100 times higher [1].\n\nThis matters because the biological effects are dose-dependent and qualitatively different at high concentrations:\n\n- Pro-oxidant effect: At pharmacologic concentrations (achievable only via IV), vitamin C generates hydrogen peroxide in extracellular fluid. Cancer cells, which typically have lower catalase activity and higher levels of labile iron, are selectively vulnerable to this oxidative stress. Normal cells can neutralize the peroxide; many cancer cells cannot [3].\n- HIF-1 alpha suppression: High-dose ascorbate may inhibit hypoxia-inducible factor, which cancer cells rely on for angiogenesis and metabolic adaptation [1].\n- Immune modulation: Pharmacologic vitamin C concentrations appear to enhance natural killer cell activity and T-cell function beyond what physiologic levels achieve [1].\n\nThe Marik protocol gained widespread attention in 2017 when Dr. Paul Marik published a before-and-after study suggesting that a combination of IV vitamin C, hydrocortisone, and thiamine dramatically reduced mortality in sepsis patients. The CITRIS-ALI trial (a proper randomized controlled trial) tested high-dose IV vitamin C in sepsis with organ failure. The primary endpoint of organ failure scores showed no significant improvement, but 96-hour mortality and ICU length of stay were significantly reduced in the vitamin C group [2]. Subsequent larger trials (VITAMINS, VICTAS) produced mixed results, and the initial enthusiasm has been tempered.\n\nBowel tolerance dosing is a concept from orthomolecular medicine: you increase oral vitamin C until it causes loose stools, then back off slightly. Proponents claim this threshold rises during illness, reflecting increased tissue demand. While the concept has some logical basis — tissues do consume more vitamin C during infection and oxidative stress — it lacks rigorous clinical validation as a dosing strategy.\n\nOral vitamin C at higher doses (1-3 grams per day in divided doses) is generally safe for most people. Potential concerns include increased oxalate excretion (relevant for those prone to kidney stones) and interference with certain lab tests [1].","deepText":"The landmark 2005 NIH study by Chen et al. demonstrated the selective cytotoxicity mechanism that explained why Pauling's oral vitamin C cancer trials failed while his IV-based observations had some merit [3]. Using pharmacologic concentrations of ascorbate achievable only by IV, they showed that hydrogen peroxide was generated in extracellular fluid at rates sufficient to kill cancer cells while sparing normal cells. This paper essentially restarted serious academic interest in high-dose vitamin C as a cancer therapy after decades of dismissal.\n\nOhno et al. (2009) reviewed and re-evaluated high-dose vitamin C therapy in cancer treatment [1]. They noted that interest among physicians and scientists had grown as research on ascorbate pharmacokinetics and its mechanisms of action against tumor cells was published, and as case studies continued to accumulate suggesting that ascorbate therapy could be effective if the right protocols were used. The authors argued that ascorbate in cancer treatment deserves re-examination.\n\nThe CITRIS-ALI trial (Fowler et al., 2019) randomized 167 patients with sepsis and acute respiratory distress syndrome to receive either IV vitamin C (50 mg/kg every 6 hours for 96 hours) or placebo [2]. The primary composite outcome of modified SOFA score change did not differ significantly between groups. However, the vitamin C group showed a significant reduction in 96-hour all-cause mortality (29.8% vs 46.3%, p=0.03) and more ICU-free days. These secondary findings, while provocative, require confirmation in larger trials.","deepTruncated":false,"references":[{"id":"1","title":"High-Dose Vitamin C (Ascorbic Acid) Therapy in the Treatment of Patients with Advanced Cancer","authors":"Ohno S, Ohno Y, Suzuki N, Soma G, Inoue M","year":2009,"journal":"Anticancer Research","pmid":"19414313","url":"https://pubmed.ncbi.nlm.nih.gov/19414313/"},{"id":"2","title":"Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients with Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial","authors":"Fowler AA, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, et al.","year":2019,"journal":"JAMA","pmid":"31573637","url":"https://pubmed.ncbi.nlm.nih.gov/31573637/"},{"id":"3","title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","authors":"Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M","year":2005,"journal":"Proceedings of the National Academy of Sciences","pmid":"16157892","url":"https://pubmed.ncbi.nlm.nih.gov/16157892/"}],"wordCount":715,"source":{"path":"src/content/topics/vitamin-c/high-dose-vitamin-c.md"},"citeAs":"“Does high-dose IV vitamin C treat cancer or sepsis?.” What's Healthy and Why. https://whatshealthyandwhy.com/vitamin-c/high-dose-vitamin-c","notice":"General information backed by peer-reviewed research, not medical advice."}